OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Release Date
2025
(3)
2019
(2)
2024
(1)
2023
(1)
2018
(1)
2015
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Three-dimensional cage-like microscaffolds for cell invasion studies.
Not available
S-EPMC4650598
|
biostudies-literature
Cite
The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.
Not available
S-EPMC6888416
|
biostudies-literature
Cite
Cerivastatin Synergizes with Trametinib and Enhances Its Efficacy in the Therapy of Uveal Melanoma.
Not available
S-EPMC9913575
|
biostudies-literature
Cite
Soluble CTLA-4 as a favorable predictive biomarker in metastatic melanoma patients treated with ipilimumab: an Italian melanoma intergroup study.
Not available
S-EPMC11028053
|
biostudies-literature
Cite
High BRAF variant allele frequency predicts poor outcomes in metastatic melanoma patients treated with BRAF/MEK inhibitors.
Not available
S-EPMC12713232
|
biostudies-literature
Cite
Phase II study of retifanlimab in patients with recurrent locally advanced or metastatic Merkel cell carcinoma (POD1UM-201).
Not available
S-EPMC12359524
|
biostudies-literature
Cite
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist.
Not available
S-EPMC5849634
|
biostudies-literature
Cite
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial.
Not available
S-EPMC10761671
|
biostudies-literature
Cite
Association of intraoperative end-tidal CO<sub>2</sub> levels with postoperative outcomes: a patient-level analysis of two randomised clinical trials.
Not available
S-EPMC12799414
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets